XXXX affects maternal sanity, thyroid hormones and fetal health: a prospective case control study.

@entity1 @entity308 @entity390 @entity417 @entity391 @entity7494 @entity1592
PURPOSE: @entity7494 ( @entity7494 ) is a condition of severe @entity390 or @entity391 accompanied by various complications during pregnancy. In the present study, we aimed to demonstrate the effects of @entity7494 on mother and fetus health. METHODS: Control and case group were arranged from 50 healthy pregnant @entity1 and 50 pregnant @entity1 with @entity7494 . Information about the @entity1 @entity1 was gathered with data collection form and Beck's @entity308 Inventory (BDI) and State Anxiety Inventory (SAI) were administered to the @entity1 . Following an abortion or delivery, the data about birth complications and neonatal health were collected. All laboratory results (blood count, thyroid hormones, electrolyte values and biochemical parameters) were gathered from the laboratory information system used in the hospital. RESULTS: It was found that in the case group, mean postpartum weight, serum hemoglobin, hematocrit and thyroid stimulant hormone levels were lower than control group (p  <  0.01). Conversely, case group @entity1 have higher T3 and T4 levels than control group (p  <  0.01). There was no significant difference between the two groups in terms of @entity1592 , low birth weight and abortion but it was observed that @entity1 with @entity7494 had often delivered prematurely. The mean scores of BDI and SAI in the case group were higher than those of control group. CONCLUSION: These results suggested that @entity7494 may have adverse effects on both mother and baby's health. Pregnant @entity1 with @entity7494 should be provided with training and consultancy services and be closely monitored in terms of @entity417 and thyroid hormones.
